Observations in this study confirm these trends. In addition, the emulsifier has been found to enhance the interparticle attraction. (C) 2009 Wiley Periodicals, Inc. J Appl Polym Sci 115: 3605-3609, 2010″
“Objective: To investigate whether Escherichia coli bacteriuria is associated with the development of hypertension during a long-term follow-up.
Methods: A prospective cohort study was performed among the participants of two population-based studies. Between 1974 and 1986 all women 4SC-202 ic50 aged 39 to 68 years old, who lived in Utrecht, the Netherlands, were invited to participate in a breast cancer screening program. The participants completed
a questionnaire, underwent a medical examination, and collected a morning urine sample that remained stored. From 1993 to 1997 another
population-based study was performed. We performed a full cohort analysis for 444 women who participated in this website both studies. E. coli bacteriuria was diagnosed by a real-time PCR. Hypertension was defined as the use of antihypertensive medication and/or a measured systolic blood pressure of at least 160 mmHg or a diastolic blood pressure of 95 mmHg or higher. The mean follow-up was 11.5 +/- 1.7 years.
Results: Forty women (9%) had E. coli bacteriuria at baseline. Women who had bacteriuria at baseline had a mean blood pressure at study endpoint of 133 +/- 20 mmHg systolic and 78 +/- 11 mmHg diastolic, and women without bacteriuria had values of 129 +/- 20 and 78 +/- 11 mmHg, respectively (p-values for difference 0.33 and 0.88). Although E. coli bacteriuria was not associated with the blood pressure as a continuous variable, it was associated with the development of hypertension during follow-up (OR 2.8, 95% CI 1.4-5.5).
Conclusion: E. coli bacteriuria may increase the risk of future hypertension. (C) 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.”
“Purpose:
learn more To increase our knowledge of how nurses assess breakthrough cancer pain (BTCP); and whether they find it difficult to distinguish BTCP from background pain; how they estimate the impact of BTCP on patients’ daily lives, and the factors that nurses consider to induce BTCP. Variations in their use of assessment tools and their ability to distinguish between different types of pain were also examined in terms of the number of years of oncology nursing experience and the practice in different countries.
Methods: In total, 1241 nurses (90% female) who care for patients with cancer, from 12 European countries, completed a survey questionnaire.
Key results: Half the sample had >9 years of experience in oncology nursing. Although 39% had no pain assessment tool to help them distinguish between types of pain, 95% of those who used a tool found it useful. Furthermore, 37% reported that they had problems distinguishing background pain from BTCP. Movement was identified as the factor that most commonly exacerbated BTCP across all countries.